SLAM
AUPH icon

Swiss Life Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Swiss Life Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$291K Buy
17,140
+884
+5% +$14.1K ﹤0.01% 1285
2026
Q1 		$241K Buy
16,256
+976
+6% +$14.3K ﹤0.01% 1263
2025
Q4 		$244K Buy
+15,280
New +$217K ﹤0.01% 1151

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return

Swiss Life Asset Management's AUPH Position: Q2 2026 in Review

Swiss Life Asset Management increased its Aurinia Pharmaceuticals (AUPH) stake by 5.4% in Q2 2026, buying an estimated $14.1K and bringing the position to 17,140 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #1285.

Swiss Life Asset Management first reported a position in AUPH in Q4 2025 and has held it in 3 quarters since. 171 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Swiss Life Asset Management held 17,140 shares of Aurinia Pharmaceuticals worth $291K as of Q2 2026.
  • Swiss Life Asset Management bought 884 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $14.1K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1285 holding.
  • Swiss Life Asset Management first reported a position in Aurinia Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 171 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.